Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 61   

Articles published

GNOM 3.14
price chart
New Market Research Report: Complete Genomics, Inc. - Mergers ...
Recently published research from MarketLine, "Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report", is now available at Fast Market Research.
Related articles »  
Market Outlook: Non-Invasive Prenatal Screening Poised For Significant Growth
In March 2014, Ariosa Diagnostics, Inc. filed a preliminary S-1 with the SEC, which began their mandatory 21-day waiting period prior to an Initial Public Offering (IPO).
Related articles »  
Sheikha Moza meets Japanese emperor, CEO of Sony Corporation
The students said that the ir reason for choosing Japan to complete their higher education is the country's progress in the fields of scientific research and engineering, as well as their willingness to recognise the unique Japanese culture which has ...
Related articles »  
23andMe Appoints Dr. Jill Hagenkord Chief Medical Officer
Prior to joining Invitae, Hagenkord served as chief medical officer and senior vice president at Complete Genomics, Inc. Her other prior experiences include founder and chief medical officer for iKaryos Diagnostics, associate professor of pathology at ...
Related articles »  
Life Sciences Chrome
Growth in the use of chromatography techniques in research activities in the fields of medicine, proteomics, metabolomics and genomics also propels the growth of the market. According to Transparency ... JM Science offers a complete line of Shiseido ...
What's a Good Small Cap Genomics Stock? ROSG, GHDX & CLRX
Small cap genomics stocks Rosetta Genomics Ltd (ROSG), Genomic Health, Inc (GHDX) and CollabRx Inc (CLRX) are at the forefront of genomics testing or research, but their performance for investors has been mixed. ... I should mention that Wikipedia ...
Related articles »  
Metabolic Medical Institute (MMI) to Host Healthy Aging Therapeutics ...
Leonard Pershing Guarente, PhD is co-chair of the Scientific Advisory Board at Sirtris Pharmaceuticals, Inc., is the Novartis Professor of Biology at MIT, and serves on the Advisory Board of Segterra Inc. � David Sinclair, PhD is a Professor of ...
Related articles »  
March News and Product Briefs
Empiriko, a clinical intelligence company, and Interchim, Inc., a creator of laboratory instruments, announced a partnership to link Interchim's PuriFlash mass spectrometry technology with Empiriko's Biomimiks chemosynthetic livers, for near real-time ...
Photo: Courtesy Alltech Staff
Now, some horses hardly graze at all and instead receive a complete balanced ration twice or thrice daily. One look at the hundreds of feed and supplement options ... She says equine microarrays�tools researchers use to assess the turning on and off ...
Related articles »  
Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for ...
BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
Related articles »